Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways
Cisplatin, as the first-line anti-tumor agent, is widely used for treatment of a variety of malignancies including non-small cell lung cancer (NSCLC).However, the acquired resistance has been a major obstacle for the clinical application.Scutellarin is Disk a active flavone extracted from Erigeron breviscapus Hand-Mazz that has been shown to exhibi